Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total revenues by Quarter
Crinetics Pharmaceuticals — Total revenues ($M) ($M)
Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total revenues: $25.1M in Q2 2026, up 2,338.8% from a year earlier. That is the highest of the 31 quarters on record here.
Where the Q2 2026 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001699813 Crinetics Pharmaceuticals).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Crinetics Pharmaceuticals — Total revenues ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 25.1 | +2,338.8% | SEC Filing ↗ |
| Q1 2026 | Mar 31, 2026 | 10.7 | +2,880.6% | SEC Filing ↗ |
| Q4 2025 | Dec 31, 2025 | 6.17 | – | SEC Filing ↗ |
| Q3 2025 | Sep 30, 2025 | 0.14 | – | SEC Filing ↗ |
| Q2 2025 | Jun 30, 2025 | 1.03 | +157.5% | SEC Filing ↗ |
| Q1 2025 | Mar 31, 2025 | 0.36 | -43.7% | SEC Filing ↗ |
| Q4 2024 | Dec 31, 2024 | 0 | -100.0% | SEC Filing ↗ |
| Q3 2024 | Sep 30, 2024 | 0 | -100.0% | SEC Filing ↗ |
| Q2 2024 | Jun 30, 2024 | 0.40 | -59.6% | SEC Filing ↗ |
| Q1 2024 | Mar 31, 2024 | 0.64 | -76.1% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | -0.01 | -99.8% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 0.35 | -23.9% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 0.99 | +125.0% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 2.68 | -14.4% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | -4.03 | – | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 0.46 | – | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 0.44 | – | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 3.13 | – | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 0 | – | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 0 | – | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 0 | -100.0% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 0 | -100.0% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 0 | -100.0% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 0.07 | -81.1% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 0.32 | -59.0% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 0.51 | -7.3% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 0.37 | -15.9% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 0.78 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 0.55 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 0.66 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 0.44 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total revenues ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/crinetics-rev
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.